Imagine a pill or capsule that breaks down very slowly, taking days to treat various other diseases like Malaria inside the body. That is how MIT's latest medical breakthrough- a slow-breaking "pill" is hitting the healthcare industry today.

The idea about the pill popped up in the minds in a team of medical researchers in the Massachusetts Institute of Technology. A member of the certain team that developed the pill in the US, prof. Robert Langer was one of the random researchers in the institute who started off with a thought that most modern pills' effects do not last even for a day. And, if these would last, can be most adversarial to the body.

Since the only solution for prolonging the effect of drugs in the body by upping its dosage can instead be a serious threat, Prof. Langer thought that making it stay longer in the body would be safer. And, so the thought gave birth to an idea and the idea gave birth to a plan.

More so, it eventually enticed medical discourses and the possibilities of ultra-long-lasting oral systems. Hence, in just a matter of months, Prof. Robert Langer finds himself distributing slow-breaking "pills' among healthcare systems in the US, the Guardian reported.

The pill works, as per design by the researchers at MIT and Brigham and Women's Hospital, as a drug capsule that remains in the stomach for as long as 2 weeks after being swallowed. The key achievement of this "pill" is the gradual dose release treatment.

Such treatment saves a bunch-load of adverse effects from repeated intakes and organizes an organic system of treatment in the body. With the pill's focused treatment system, various diseases like Malaria, brain disorders like Alzheimer's disease can surely be listed off the body, MIT News reported.

As per "Nov. 16 issue of Science Translational Medicine" by a team of researchers Langer, Koch, Traverso, etc. the drug is named Ivermectin. By the funding aids of the National Institutes of Health, Bill and Melinda Gates Foundation and the Max Planck Research Award, this team of researchers from MIT is now introducing its latest powerful slow-breaking "pill" to healthcare institutions in the US and hopefully soon, the world, Quartz reported.